Section 1 Short title
This Act may be cited as the “Defense Production and Active Pharmaceutical Ingredients Act”.
Defense Production and Active Pharmaceutical Ingredients Act
A BILL
To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients.
Sec. 2 Modification of support for research and development of bioindustrial manufacturing processes
Section 215(c)(1) of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (Public Law 117–263; 10 U.S.C. 4841 note) is amended by inserting “active pharmaceutical ingredients, key starting materials for such ingredients,” after “commodity chemicals,”.